Evidence map›Paper›PMID 39909188›Full record

ArticleMolecular metabolism2025

HINT1 suppression protects against age-related cardiac dysfunction by enhancing mitochondrial biogenesis.

Michio Sato, Tsuyoshi Kadomatsu, Jun Morinaga, Yuya Kinoshita, Daisuke Torigoe, Haruki Horiguchi, Sumio Ohtsuki, Shuji Yamamura, Ryoko Kusaba, Takanori Yamaguchi and 6 more

Abstract read
In one paragraph

Article in Molecular metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Michio SatoDepartment of Molecular Genetics, Kumamoto University, Kumamoto, Japan; Center for Metabolic Regulation of Healthy Aging (CMHA), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Division of Kumamoto Mouse Clinic (KMC), Institute of Resource Developmental and Analysis (IRDA), Kumamoto University, Kumamoto, Japan; Department of Cardiovascular Medicine, School of Medicine, Saga University, Saga, Japan.
Tsuyoshi KadomatsuDepartment of Molecular Genetics, Kumamoto University, Kumamoto, Japan; Center for Metabolic Regulation of Healthy Aging (CMHA), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. Electronic address: tkado@gpo.kumamoto-u.ac.jp.
Jun MorinagaDepartment of Molecular Genetics, Kumamoto University, Kumamoto, Japan.
Yuya KinoshitaDepartment of Molecular Genetics, Kumamoto University, Kumamoto, Japan.
Daisuke TorigoeDivision of Experimental Genetics, IRDA, Kumamoto University, Kumamoto, Japan.
Haruki HoriguchiDepartment of Molecular Genetics, Kumamoto University, Kumamoto, Japan; Center for Metabolic Regulation of Healthy Aging (CMHA), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Department of Aging and Geriatric Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Sumio OhtsukiDepartment of Pharmaceutical Microbiology, Graduate School of Pharmacological Sciences, Kumamoto University, Kumamoto, Japan.
Shuji YamamuraDepartment of Molecular Genetics, Kumamoto University, Kumamoto, Japan.
Ryoko KusabaDepartment of Molecular Genetics, Kumamoto University, Kumamoto, Japan.
Takanori YamaguchiDepartment of Cardiovascular Medicine, School of Medicine, Saga University, Saga, Japan.
Goro YoshiokaDepartment of Cardiovascular Medicine, School of Medicine, Saga University, Saga, Japan.
Kimi ArakiCenter for Metabolic Regulation of Healthy Aging (CMHA), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Division of Developmental Genetics, IRDA, Kumamoto University, Kumamoto, Japan.
Tomohiko WakayamaDepartment of Histology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Keishi MiyataDepartment of Molecular Genetics, Kumamoto University, Kumamoto, Japan.
Koichi NodeDepartment of Cardiovascular Medicine, School of Medicine, Saga University, Saga, Japan.
Yuichi OikeDepartment of Molecular Genetics, Kumamoto University, Kumamoto, Japan; Center for Metabolic Regulation of Healthy Aging (CMHA), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Department of Aging and Geriatric Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. Electronic address: oike@gpo.kumamoto-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCardiac function declines with age, impairing exercise tolerance and negatively impacting healthy aging. However, mechanisms driving age-related declines in cardiac function are not fully understood.

methodsWe examined mechanisms underlying age-related cardiac dysfunction using 3- and 24-month-old wild-type mice fed ad libitum or 24-month-old wild-type mice subjected to 70% calorie restriction (CR) starting at 2-month-old. In addition, cardiac aging phenotypes and mitochondrial biogenesis were also analyzed in 25-month-old cardiac-specific Hint1 knockout mice, 24-month-old CAG-Caren Tg mice, and 24-month-old wild-type mice injected with AAV6-Caren.

resultsWe observed inactivation of mitochondrial biogenesis in hearts of aged mice. We also showed that activity of the BAF chromatin remodeling complex is repressed by HINT1, whose expression in heart increases with age, leading to decreased transcription of Tfam, which promotes mitochondrial biogenesis. Interestingly, CR not only suppressed age-related declines in cardiac function and mitochondrial biogenesis but blocked concomitant increases in cardiac HINT1 protein levels and maintained Tfam transcription. Furthermore, expression of the lncRNA Caren, which inhibits Hint1 mRNA translation, decreased with age in heart, and CR suppressed this effect. Finally, decreased HINT1 expression due to Caren overexpression antagonized age-related declines in mitochondrial biogenesis, ameliorating age-related cardiac dysfunction, exercise intolerance, and exercise-induced cardiac damage and subsequent death of mice.

conclusionOur findings suggest that mitochondrial biogenesis in cardiomyocytes decreases with age and could underlie cardiac dysfunction, and that the Caren-HINT1-mitochondrial biogenesis axis may constitute a mechanism linking CR to resistance to cardiac aging. We also show that ameliorating declines in mitochondrial biogenesis in cardiomyocytes could counteract age-related declines in cardiac function, and that this strategy may improve exercise tolerance and extend so-called "healthy life span".

Indexed as

AgingMitochondria, HeartNerve Tissue ProteinsOrganelle BiogenesisAnimalsCaloric RestrictionDNA-Binding ProteinsMaleMiceMice, Inbred C57BLMice, KnockoutMitochondriaMitochondrial ProteinsMyocytes, CardiacTranscription FactorsDNA-Binding ProteinsMitochondrial ProteinsNerve Tissue ProteinsTranscription FactorsCalorie restrictionCardiac agingHeart failureMitochondrial biogenesis

Identifiers

PMID39909188
PMCPMC11850129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.